Maryland healthcare providers are being urged to utilize regulatory flexibilities under the Total Cost of Care (TCOC) Model, as highlighted by recent communications from legal experts and industry analysts. The Maryland Pharmacy Drug Affordability Board (PDAB) has also released a draft Upper Payment Limit Action Plan, emphasizing the ongoing regulatory changes affecting healthcare reimbursement. Additionally, the Centers for Medicare & Medicaid Services (CMS) is reviving and expanding proposed changes to the Medicare Overpayment Rule, which could significantly impact healthcare providers' operations. These developments underscore the importance for providers to remain compliant with evolving regulations and to pay close attention to prior authorization processes, as regulators are increasingly vigilant in these areas.